TraceLink to Present at the 39th Annual J.P. Morgan Healthcare Conference
Jan 11, 2021, 11:46 ET
NORTH READING, Mass., Jan. 11, 2021 /PRNewswire/ -- TraceLink Inc., the leading digital platform company for the life sciences industry, today announced that, for the fifth consecutive year, Shabbir Dahod, president and CEO of TraceLink, will present at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14 at 8:40 am EST via virtual webcast.
During his presentation, Dahod will discuss the long-term global market opportunity for TraceLink, including the Company's unique position in digitally transforming the healthcare industry with its Opus digital supply network platform.
About TraceLink
TraceLink is the leading digital platform company for the life science supply chain, bringing hundreds of thousands of pharmaceutical and healthcare organizations together for the greater good of the patient. TraceLink's digital solutions bring the precision, agility and visibility necessary for all members of the pharmaceutical ecosystem to thrive in a world where unplanned events and business disruptions are the "next normal." With headquarters in Massachusetts, TraceLink has six global offices through North America, South America, Europe, and Asia. For more information on TraceLink, visit www.tracelink.com.
TraceLink is funded by Georgian Partners, Willett Advisors LLC, Vulcan Capital, Goldman Sachs, FirstMark Capital, Volition Capital and F-Prime Capital.
SOURCE TraceLink Inc.
